Frontlight ResearchEarly access
Trial site
Richmond Pharmacology Ltd
- 1running trial
- 3closed trials
The trials here
What the 4 trials at this site are about, from their registry records.
- Conditions
- Amyloidosis1 trial
- Type 2 diabetes1 trial
- Wilson disease1 trial
- Phase
- Phase 11 trial
- Phase 1/21 trial
- Phase 31 trial
- Status
- Completed2 trials
- Active, not recruiting1 trial
- Terminated1 trial
- Lead sponsor
- ADARx Pharmaceuticals, Inc.1 trial
- Eidos Therapeutics, a BridgeBio company1 trial
- Orphalan1 trial
- Richmond Pharmacology Limited1 trial
Running trials
Active, not recruiting
Open-Label Safety Study of Acoramidis (AG10) in Symptomatic ATTR Participants
Closed trials
Completed
Recruiting
Terminated
Effect of Hyperglycaemia and Moxifloxacin on QTc Interval in T2DM
Site data: ClinicalTrials.govUpdated 15 Nov 2026